Does METHYLPREDNISOLONE Cause Mobility decreased? 1,251 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,251 reports of Mobility decreased have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 2.0% of all adverse event reports for METHYLPREDNISOLONE.
1,251
Reports of Mobility decreased with METHYLPREDNISOLONE
2.0%
of all METHYLPREDNISOLONE reports
1,056
Deaths
954
Hospitalizations
How Dangerous Is Mobility decreased From METHYLPREDNISOLONE?
Of the 1,251 reports, 1,056 (84.4%) resulted in death, 954 (76.3%) required hospitalization, and 864 (69.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 1,251 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which METHYLPREDNISOLONE Alternatives Have Lower Mobility decreased Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE